2015
DOI: 10.1097/dad.0000000000000209
|View full text |Cite
|
Sign up to set email alerts
|

Basaloid Carcinoma of the Breast Mimicking Cutaneous Basaloid Neoplasms

Abstract: Basaloid carcinoma of the breast (BCB) is a rare, triple-negative aggressive primary breast tumor that can closely mimic cutaneous basal cell carcinoma (BCC), neuroendocrine tumors, adnexal neoplasms, and other primary breast tumors. Accurate diagnosis of this tumor is critical for appropriate clinical management. We add to the literature 2 female patients with BCB presenting with a nipple mass. Histopathologic findings from both patients showed dermal nests and cords of atypical basaloid cells with epidermal … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 30 publications
0
1
0
Order By: Relevance
“…In our case, diagnosis was made mainly on the basis of histological findings; we have excluded a primary breast carcinoma because of the typical basaloid pattern of the neoplastic cells; moreover, the long‐time clinical history of this patient was consistent with a cutaneous low‐grade tumor. On the other hand, a basaloid histological type of breast carcinoma is not considered in WHO classification, although a unique case of basaloid carcinoma of the breast has been recently reported . Immunohistochemical tools seem to be not specific for differential diagnosis; for instance, most of the BCC are positive for BerEP4 antibody; however, this marker is shared in many other tumors.…”
Section: Discussionmentioning
confidence: 99%
“…In our case, diagnosis was made mainly on the basis of histological findings; we have excluded a primary breast carcinoma because of the typical basaloid pattern of the neoplastic cells; moreover, the long‐time clinical history of this patient was consistent with a cutaneous low‐grade tumor. On the other hand, a basaloid histological type of breast carcinoma is not considered in WHO classification, although a unique case of basaloid carcinoma of the breast has been recently reported . Immunohistochemical tools seem to be not specific for differential diagnosis; for instance, most of the BCC are positive for BerEP4 antibody; however, this marker is shared in many other tumors.…”
Section: Discussionmentioning
confidence: 99%